Is Foot-Numbing Spray The Solution To High-Heel Pain?

By Emma Koch - 21Alive

Is Foot-Numbing Spray The Solution To High-Heel Pain?

December 27, 2013 Updated Dec 27, 2013 at 11:17 AM EDT

NATIONAL (ABC News) -- Wearing high heels can be a real pain for women, but a new product claims to make wearing even the highest of stilettos comfortable with just a simple spray.

The product, Heel No Pain/Style by Biochemistry, was created by Dr. Randal Haworth, a Beverly Hills plastic surgeon.

Among its ingredients is lidocaine HCI, a local anesthetic used by doctors and dentists, according to Haworth. The product’s Facebook page reports the anesthetic is designed to work its way through the thick skin on the soles of the feet and numb the nerves that transmit pain.

The spray is to be applied to your feet no more than four times a day. After 10 to 15 minutes, the company claims, the spray will kick in and ease your pain.

While the company calls the spray a “whole new way to stay happy in your heels,” some doctors question whether it is smart to mask, rather than fix, the pain in your feet.

“It’s not really curing a problem. It’s really just masking the pain,” said Dr. Jaime Hernandez, an orthopedic surgeon at the Southern California Orthopedic Institute. “It’s important to listen and receive any signals the body is sending to you.”

ABC News’ Cecilia Vega gave the product a try, spraying one foot to see what happens.

“The foot without the spray, it feels like a foot that’s been in a high heel all day long. It kind of hurts,” Vega said. “The foot with the spray, it kind of hurts too. I don’t really notice that much of a difference.”

Dr. Haworth says the product is effective on about 70 percent of the people who try it.

The cucumber-scented spray will go on sale in 2014 and comes in a 1-ounce bottle and a 2-ounce ounce bottle.

What are your thoughts CLICK HERE to leave us a "QUESTION OF THE DAY” comment.

© Copyright 2016, A Quincy Media broadcasting station. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

To submit a comment on this article, your email address is required. We respect your privacy and your email will not be visible to others nor will it be added to any email lists.